BS
Basilea Pharma
BSLN.SW·SIXBasel CHFounded 2000100 employees
Small CapbiotechPublicInfectious Disease
Platform: Cresemba Antifungal
Market Cap
$0.3B
All Drugs
2
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (BSLN.SW)
Loading BSLN.SW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BSL-7024 | BSL-7024 | Phase 1 | 2 | WRN | SCD | ||
| Daranesiran | BSL-7399 | Approved | 4 | JAK2 | IPF |
SEC Filings & Financial Documents
SEC filings are not available for SIX-listed companies.
Basilea Pharma trades on SIX (CH). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)